Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Volumn 11, Issue 1-2, 2010, Pages 194-202

  Baumann, Fusun ^a,c   Henderson, Robert D ^a   Morrison, Stephen C ^b   Brown, Michael ^b   Hutchinson, N ^a   Douglas, James A ^c   Robinson, Peter J ^c   McCombe, Pamela A ^c  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

Amyotrophic lateral sclerosis; Biomarkers; Prognostic; Respiratory function tests; Survival

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; KAPLAN MEIER METHOD; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MAXIMAL EXPIRATORY PRESSURE; MAXIMAL INSPIRATORY PRESSURE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT PARAMETERS; SENSITIVITY AND SPECIFICITY; SITTING; SPIROMETRY; SUPINE POSITION; SURVIVAL; SURVIVAL TIME;

AMYOTROPHIC LATERAL SCLEROSIS; EXHALATION; FEMALE; HUMANS; INHALATION; KAPLAN-MEIERS ESTIMATE; LINEAR MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RESPIRATORY FUNCTION TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPIROMETRY; VITAL CAPACITY;

EID: 77649276872     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482960902991773     Document Type: Article

References (26)

1. Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D, et al. Causes of death in a post mortem series of ALS patients. Amyotroph Lateral Scler. 2008;9:59-62.
2. Talman P, Forbes A, Mathers S. Clinical phenotypes and natural progression for motor neuron disease: analysis from an Australian database. Amyotroph Lateral Scler. 2009;10: 79-84.
3. Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis. (An evidencebased review). Muscle Nerve. 1999;22:1104-18.
4. Schiffman PL, Belsh JM. Pulmonary function at diagnosis of amyotrophic lateral sclerosis: rate of deterioration. Chest. 1993;103:508-13.
5. Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology. 1998;50:66-72.
6. Mendoza M, Gelinas DF, Moore DH, Miller RG. A comparison of maximal inspiratory pressure and forced vital capacity as potential criteria for initiating non-invasive ventilation in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:106-11.
7. Czaplinski A, Yen AA, Appel SH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry. 2006;77:390-2.
8. Lechtzin N, Wiener CM, Shade DM, Clawson L, Diette GB. Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis. Chest. 2002;121:436-42.
9. Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, et al. EALSC Working Group. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler. 2007;8:195-213.
10. Allen SM, Hunt B, Green M. Fall in vital capacity with posture. Br J Dis Chest. 1985;79:267-71.
11. Schmidt EP, Drachman DB, Wiener CM, Clawson L, Kimball R, Lechtzin N. Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design. Muscle Nerve. 2006;33:127-32.
12. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. ATS/ERS Task Force. Standardization of spirometry. Eur Respir J. 2005;26:319-38.
13. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Lung volume and forced ventilatory flows. Report of Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J. 1993;6(Suppl 16):S5-40.
14. Wilson SH, Cooke NT, Edwards RHT, Spiro SG. Predicted normal values for maximal respiratory pressures in Caucasian adults and children. Thorax. 1984;39:535-8.
15. Traynor BJ, Zhang H, Shefner JM, Schoenfeld D, Cudkowicz ME,. NEALS Consortium. Functional outcome measures as clinical trial endpoints in ALS. Neurology. 2004;63:1933-5.
16. Vender RL, Mauger D, Walsh S, Alam S, Simmons Z. Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival. Amyotroph Lateral Scler. 2007;8:36-41.
17. Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, et al. Western ALS Study Group. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomized trial. Lancet Neurol. 2007;6:1045-53.
18. De Long ER, de Long DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a non-parametric approach. Biometrics. 1988;44:837-45.
19. Koch HJ, Hau P. ROC analysis as an additional method to characterize time-to-event data. Pathol Oncol Res. 2005;11: 50-2.
20. Jackson CE, Rosenfeld J, Moore DH, BryanWW, Barohn RJ, Wrench M, et al. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci. 2001;191:75-8.
21. Baydur A, Adkins RH, Milic-Emili J. Lung mechanics in individuals with spinal cord injury: effects of injury level and posture. J Appl Physiol. 2001;90:405-11.
22. Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2005;171:269-74.
23. Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve. 2002;25:709-14.
24. Armon C, Graves MC, Moses D, Forte DK, Sepulveda L, Darby SM, Smith RA. Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis. Muscle Nerve. 2000;23:874-82.
25. Fitting JW, Paillex R, Hirt L, Aebischer P, Schluep M. Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol. 1999;46: 887-93.
26. Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain. 2001;124:2000-13.